Skip to main content
IMPEDIMED LIMITED logo

IMPEDIMED LIMITED — Investor Relations & Filings

Ticker · IPD ISIN · AU000000IPD8 LEI · 254900I3YH2IS1UEHJ67 ASX Manufacturing
Open in API
Filings indexed 1,549 across all filing types
Latest filing 2026-05-12 Proxy Solicitation & In…
Country AU Australia
Listing ASX IPD

About IMPEDIMED LIMITED

https://www.impedimed.com

ImpediMed Limited is a medical technology company specializing in the development and commercialization of non-invasive devices utilizing bioimpedance spectroscopy (BIS) technology. The company's core focus is the early detection and management of secondary lymphedema in oncology patients, particularly those undergoing treatment for breast cancer. Its flagship product, the SOZO digital health platform, provides rapid and precise measurements of extracellular fluid, total body water, and body composition. Beyond oncology, the technology is applied to the clinical monitoring of chronic heart failure and other conditions characterized by fluid imbalance. By delivering actionable data through its BIS technology, ImpediMed enables clinicians to implement early interventions and personalized care strategies. The platform is designed for seamless integration into clinical workflows to support longitudinal patient assessment.

Recent filings

Filing Released Lang Actions
Notice of Extraordinary General Meeting 31 pages 1.0MB
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Notice of Extraordinary General Meeting (EGM) including the Explanatory Memorandum and Voting Form sent to shareholders to inform and solicit votes. It does not contain actual financial statements or results nor announce voting outcomes. It is clearly meeting materials for shareholder solicitation, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-12 English
Online Meeting Guide 6 pages 606.5KB
Proxy Solicitation & Information Statement Classification · 90% confidence The document is an Online Meeting Guide for an upcoming Extraordinary General Meeting, providing instructions for shareholders to attend, vote, and ask questions online. It is part of the proxy solicitation materials sent to shareholders in advance of the meeting, rather than the actual AGM presentation, voting results, or financial report. Therefore, it best fits the Proxy Solicitation & Information Statement category.
2026-05-12 English
Share Purchase Plan Opens 4 pages 222.4KB
Capital/Financing Update Classification · 92% confidence The document is an ASX announcement detailing the opening of a Share Purchase Plan (SPP), terms of the offer, eligible shareholders, pricing, options attached, shortfall arrangements, and key dates. It focuses on a fundraising activity (institutional placement and SPP) to raise capital. This fits squarely within the Capital/Financing Update category, which covers updates on fundraising and capital structure changes.
2026-05-11 English
Share Purchase Plan - Letters to Shareholders 7 pages 484.4KB
Share Issue/Capital Change Classification · 94% confidence The document is a set of letters dispatched to shareholders regarding the opening of a Share Purchase Plan (SPP) and includes detailed instructions on how eligible and ineligible shareholders can participate in a capital raising. It is not a financial report, earnings release, or regulatory certification; rather, it announces a new share issue under the SPP as part of a broader capital raising. Therefore, it falls under the “Share Issue/Capital Change” category.
2026-05-11 English
Becoming a substantial holder 3 pages 149.3KB
Major Shareholding Notification Classification · 95% confidence The document is an Australian Form 603 “Notice of Initial Substantial Holder” filed under the Corporations Act 2001, which reports a substantial holder’s relevant interests, voting power, and details of share acquisitions. This is a notification of a change in significant share ownership levels (crossing the 5% threshold), matching the Major Shareholding Notification definition.
2026-05-11 English
Application for quotation of securities - IPD 6 pages 18.5KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue price, and references a previous Appendix 3B announcement about the securities issuance. The document is a formal announcement related to capital raising and listing of new shares, not a financial report or earnings release. It fits the category of Capital/Financing Update as it concerns new securities issuance and quotation on the exchange.
2026-05-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.